16-21687618-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144672.4(OTOA):c.605G>C(p.Arg202Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000372 in 1,613,650 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_144672.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000336 AC: 51AN: 151850Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000434 AC: 109AN: 251128Hom.: 0 AF XY: 0.000405 AC XY: 55AN XY: 135786
GnomAD4 exome AF: 0.000376 AC: 549AN: 1461690Hom.: 0 Cov.: 33 AF XY: 0.000395 AC XY: 287AN XY: 727120
GnomAD4 genome AF: 0.000336 AC: 51AN: 151960Hom.: 0 Cov.: 31 AF XY: 0.000350 AC XY: 26AN XY: 74278
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 202 of the OTOA protein (p.Arg202Pro). This variant is present in population databases (rs142850013, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with OTOA-related conditions. ClinVar contains an entry for this variant (Variation ID: 229068). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Arg202Pro var iant in OTOA has not been previously reported in individuals with hearing loss, but has been identified in 0.09% (56/65832) European chromosomes by the Exome Ag gregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs142850013). Arginine (Arg) at position 202 is not conserved through species, with one mammal (big brown bat) having a proline (Pro) at this position, suggesting this change is tolerated. Additional computational prediction tools suggest that this varia nt may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, while the clinical significance of the Ar g202Pro variant is uncertain, these data suggest that it is more likely to be be nign. -
Inborn genetic diseases Uncertain:1
The c.605G>C (p.R202P) alteration is located in exon 7 (coding exon 7) of the OTOA gene. This alteration results from a G to C substitution at nucleotide position 605, causing the arginine (R) at amino acid position 202 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at